Pharmacogenomics Market Potential, Dynamics, Share Value, Size Analysis and Outlook to 2023 – by Teva Pharmaceutical Industries Ltd., Assurex Health Inc., Future Science Group, Pathway Genomics, etc

Pharmacogenomics Market Report include on MarketResearchFuture.com with exhaustive Study. The report aims to provide an overview of Pharmacogenomics Market Report. The report provides key statistics on the market status. Global Forecast till 2023.

The Global Pharmacogenomics Market is presumed to register 5.8% CAGR during the forecast period (2017-2023) owing to the rising prevalence of several infectious and non-infectious diseases, asserts Market Research Future (MRFR). Pharmacogenomics refers to the study of inherited variations in the human genes that affect an individual’s reaction to a specific drug. Various genetic tests are performed in pharmacogenomics to determine targeted drug therapies and treatment procedures to be adopted in order to reduce side effects and improve the results.

Drivers and Constraints Impacting the Market

With the growing prevalence of various infectious and non-infectious diseases, growing demand for personalized drugs, increasing usage in drug discovery process, and increasing awareness about the benefits of pharmacogenomics are stimulating the market during the assessment period. Pharmacogenomics offers effective treatment therapeutics which is both reliable and safe. Thus, increasing awareness about its benefits is anticipated to augment the market growth in the coming years. Also, innovation and rapid advancements of new healthcare technologies such as High Throughput Screening (HTS), next-generation sequencing, and Digital Polymerase Chain Reaction (PCR) are further influencing the market growth.

On the flip side, lack of consistency in pharmacogenomics and lack of awareness are some of the key factors considered to impede the market growth in the coming years.

Get Exclusive PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1177

Latest Industry Updates

October 31, 2018: The U.S. Food and Drug Administration has recently announced that they have approved the marketing of 23andMe’s reports on pharmacogenetics. The genetic-testing company claims are designed to assess whether the genetics will affect an individual’s ability to metabolize certain drugs which include antidepressants.

Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.

Global Pharmacogenomics Market - Competitive Analysis

Pharmacogenomics in recent years has used a new generation of technology approaches that has led to a revolution in the understanding of disease susceptibility and pathophysiology, providing enormous potential for novel therapeutic strategies.

However, with companies aiming to capture a considerable share of the market segment as early as possible, they are competing and experimenting with various advantage points. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the best strategies.

The noteworthy players operating the global market are Teva Pharmaceutical Industries Ltd. (Israel), Assurex Health Inc. (U.S.), Future Science Group (U.S.), Pathway Genomics (U.S.), Myriad Genetics Inc. (U.S.), GeneDx. (U.S.), GeneTech (U.S.), 23andMe Inc. (U.S.), and others.

Global Pharmacogenomics Market: Segmental Analysis

The global pharmacogenomics market has been segmented on the basis of application, technology, end-user, and region.

By mode of technology, the global pharmacogenomics market has been segmented into sequencing, microarray, polymerase chain reaction, and others. Among these, the sequencing segment has been sub-segmented into pyrosequencing, Sanger sequencing, next-generation sequencing, and others.

By mode of application, the global pharmacogenomics market has been segmented into cardiology, oncology, neurological disorders, and others. Among these, the oncology segment has been sub-segmented into lung cancer, breast cancer, and others.

By mode of end-users, the global pharmacogenomics market has been segmented into research organizations, hospitals, academic institute, and others.

Regional Analysis of Pharmacogenomics Market

Geographically, the pharmacogenomics market span across regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.

The American region is considered to dominate the global pharmacogenomics market and is estimated to maintain its dominance during the assessment period. The growth is attributed to the presence of developed countries such as Canada and the U.S. along with a well-developed healthcare sector. Also, growing number of patients suffering from cardiovascular diseases have stimulated the growth of the market in this region.

The European region is considered to be the second largest market owing to the availability of funds for research and development activities. Moreover, the presence of huge patient population is influencing the market positively. With the presence of developed countries such as France and Germany, the market is likely to flourish during the review period.

Asia Pacific is the fastest growing region owing to the continuously developing economies such as China and India and presence of huge patient population. Meanwhile, the Middle East and Africa hold the least share owing to the presence of poor economy, strict government policies, and low per capita healthcare expenditure in this region.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177

Some Brief Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

TOC Continued…

LIST OF TABLES

Table 1 Pharmacogenomics Industry Synopsis, 2017 – 2023

Table 2 Global Pharmacogenomics Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Pharmacogenomics Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Pharmacogenomics Market By Technology, 2017 – 2023, (USD Million)

Table 5 Global Pharmacogenomics Market By Application, 2017 – 2023, (USD Million)

Table 6 Global Pharmacogenomics Market By End Users, 2017 – 2023, (USD Million)

Continued…
Do You Have Specific Requirement? Ask To Our Experts @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Pharmacogenomics Market

Figure 3 Segmentation Market Dynamics For Global Pharmacogenomics Market

Figure 4 Global Pharmacogenomics Market Share, By Technology 2016

Figure 5 Global Pharmacogenomics Market Share, By Application 2016

Figure 6 Global Pharmacogenomics Market Share, By End Users, 2016

Continued..

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.